1. Home
  2. RDHL vs EFOI Comparison

RDHL vs EFOI Comparison

Compare RDHL & EFOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • EFOI
  • Stock Information
  • Founded
  • RDHL 2009
  • EFOI 1985
  • Country
  • RDHL Israel
  • EFOI United States
  • Employees
  • RDHL N/A
  • EFOI N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • EFOI Building Products
  • Sector
  • RDHL Health Care
  • EFOI Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • EFOI Nasdaq
  • Market Cap
  • RDHL 8.2M
  • EFOI 6.7M
  • IPO Year
  • RDHL N/A
  • EFOI 1994
  • Fundamental
  • Price
  • RDHL $5.23
  • EFOI $1.29
  • Analyst Decision
  • RDHL
  • EFOI
  • Analyst Count
  • RDHL 0
  • EFOI 0
  • Target Price
  • RDHL N/A
  • EFOI N/A
  • AVG Volume (30 Days)
  • RDHL 10.4K
  • EFOI 11.2K
  • Earning Date
  • RDHL 04-07-2025
  • EFOI 03-21-2025
  • Dividend Yield
  • RDHL N/A
  • EFOI N/A
  • EPS Growth
  • RDHL N/A
  • EFOI N/A
  • EPS
  • RDHL N/A
  • EFOI N/A
  • Revenue
  • RDHL $3,707,000.00
  • EFOI $5,975,000.00
  • Revenue This Year
  • RDHL $224.90
  • EFOI N/A
  • Revenue Next Year
  • RDHL $82.69
  • EFOI N/A
  • P/E Ratio
  • RDHL N/A
  • EFOI N/A
  • Revenue Growth
  • RDHL N/A
  • EFOI 49.86
  • 52 Week Low
  • RDHL $5.20
  • EFOI $1.14
  • 52 Week High
  • RDHL $20.28
  • EFOI $2.90
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 31.92
  • EFOI 49.57
  • Support Level
  • RDHL $5.52
  • EFOI $1.19
  • Resistance Level
  • RDHL $5.71
  • EFOI $1.26
  • Average True Range (ATR)
  • RDHL 0.27
  • EFOI 0.09
  • MACD
  • RDHL -0.04
  • EFOI -0.01
  • Stochastic Oscillator
  • RDHL 2.38
  • EFOI 38.46

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About EFOI Energy Focus Inc.

Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. It serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, wall-packs, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. It generates a majority of its sales from Military maritime products in the United States.

Share on Social Networks: